Agbaje, Andrew

Prof. Agbaje is an award-winning physician and professor (associate) of clinical epidemiology and child health who investigates the causal relationships of aerobic fitness, physical activity, sedentary behaviour, obesity, insulin resistance, dyslipidaemia, and metabolic syndrome with arterial, cardiac, liver, and kidney structure and function from childhood through young adulthood. He discovered arterial stiffness as a novel risk factor for paediatric obesity and insulin resistance, identified adolescence as the critical time to interrupt fat mass-insulin resistance pathologic cycle, and demonstrated light-intensity physical activity as a highly effective antidote for reversing excessive fat deposit induced by childhood sedentariness. Recently, he discovered waist-to-height ratio as a specific surrogate for fat mass but not muscle mass that could replace BMI in assessing childhood obesity. Subsequently, he was interviewed LIVE on BBC World News TV to discuss the novel findings. As of September/October 2023, two of Prof. Agbaje’s publications were placed in the Top 1% highly cited paper in the academic field of Clinical Medicine, while a third publication was placed in the Top 1% highly cited paper in the academic field of Biology & Biochemistry by Clarivate’s Web of Science. He has a first authored paper in Nature Communications and was interviewed LIVE on BBC World Service Radio Newsday programme on 15th Dec 2023, BBC Radio Devon on 16th Jan 2024, and BBC World News LIVE TV programme on 14th March 2024. The University of Eastern Finland recently recorded a podcast interview of his latest findings as well as a video. The Endocrine Society in US, recently recorded a podcast interview of his research and discussed his research in the prestigious Endocrine Magazine March 2024 edition. He was invited to give a press conference at the ENDO 2024 congress in Boston, US. He was interviewed by the European Association for the Study of Obesity, a federation of 36 European countries’ professional associations and subsequently had a video interview at the European Congress on Obesity. His research has received extensive press coverage, with over 2,000 media mentions in 2022 and 2023 in outlets such as BBC, CNN, The Telegraph, Daily Mail, Mirror, BILD, Infobae, Yahoo Lifestyle, Yahoo Sport, US News & World report, DocCheck, MSN, WebMD, Medscape, The Conversation, Jerusalem Post, Helsingin Sanomat, etc, potentially reaching a global audience of more than 4.5 billion. The equivalent advertising value of these news articles is more than 30 million US dollars. He is the principal investigator of the urFIT-child research group and has strong collaboration with world-renowned pediatricians, exercise physiologists, epidemiologists, and adult clinicians in Canada, US, UK, Germany, Australia, Saudi Arabia, Nigeria, etc. He has received several scientific excellence awards including the prestigious EASO-Novo Nordisk Foundation for New Investigator Award in Childhood Obesity with a 300,000 Danish Kroner (€40,000 / 44,000 USD) prize. Other awards are the Endocrine Society Award for outstanding abstract, American Heart Association’s Elizabeth Barrett-Connor Research Award in Epidemiology and Prevention (once), Jeremiah and Rose Stamler Research Award (twice), and Paul Dudley White International Scholar Award (thrice). He co-authored an American Heart Association Scientific Statement on Environmental Exposures and Pediatric Cardiology, published in Circulation. He had a video discussion of the Scientific Statement. He was an invited guest speaker to the largest mother and child center in Canada – CHU Sainte-Justine Mother and Child University Hospital Center, Canada in March 2023 to speak on the determinants of carotid intima-media thickness and arterial stiffness in pediatrics. He is an Honorary Research Fellow at the Children’s Health and Exercise Research Centre (CHERC), Department of Public Health and Sports Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK. He was recently appointed an Associate Editor in the Journal of Cachexia, Sarcopenia, and Muscle (JCSM). He serves on the editorial board of Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB), and mentors early career editorial board members. He also serves on the editorial board of Pediatric Exercise Science journal. He is an elected Fellow of the European Society of Cardiology (FESC) and an elected Fellow of the American Heart Association (FAHA). These titles of honour, symbol of excellence and lifetime achievement recognizes his significant contribution to cardiovascular field in Europe and America. He is an expert advisor to the World Health Organization’s task force on preventing childhood obesity. Primary email is andrew.agbaje@uef.fi Secondary email is a.agbaje@exeter.ac.uk